Company:  PAVMED INC. (PAVM)
Form Type:  10-Q
Filing Date:  5/28/2020 
CIK:  0001624326 
Address:  ONE GRAND CENTRAL PLACE
SUITE 4600
 
City, State, Zip:  NEW YORK, New York 10165 
Telephone:  212-949-4319 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.79  
Change: 
0.01 (0.56%)  
Trade Time: 
Sep 25  
Market Cap: 
$89.68M
Trade PAVM now with

© 2020  
Description of Business
PAVmed is a highly-differentiated multi-product technology medical device company organized to advance a broad pipeline of innovative medical technologies from concept to commercialization, employing a business model focused on capital efficiency and speed to market. Since inception on June 26, 2014, the Company's activities have focused on advancing its lead products towards regulatory approval and commercialization, protecting its intellectual property, and building its corporate infrastructure and management team. The Company operates in one segment as a medical device company with four operating divisions which include GI Health, Minimally Invasive Interventions, Infusion Therapy, and Emerging Innovations. As resources permit, we will continue to explore internal and external innovations that fulfill our project selection criteria without limiting ourselves to any target specialty or condition.
Register and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      Item 1. Financial Statements
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      Note 2 - Financial Condition, Going Concern and Management Plans
        Note 14 - Subsequent Events
      Item 4. Controls and Procedures
    PART II. OTHER INFORMATION
      Item 6. Exhibits
    SIGNATURE
    EXHIBIT INDEX
  EXHIBIT 31.1
    CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,